	Prospective Multicenter Observational Study of Anlotinib in Advanced Non-Small Cell Lung Cancer: Real-World Evidence From China. Thorac Cancer Wang J, Dong Y, Cao F, Ran R, Yin Y, Li Y, Fu Y, Xu Y, Kuang L, Chen G, Qu G, Li J, Luo Z, Song Q, Chen Y, Xu X, Yi T, Chu Q. PMID: 42246683 [PubMed - in process]
	A practical framework of preoperative imaging for non-small cell lung cancer: Thoracic surgeons' expectations from radiologists. Tumori Kumbasar U, Durhan G. PMID: 42246403 [PubMed - as supplied by publisher]
	Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic model. Health Technol Assess Pedder H, Manzano CL, Claxton L, Whiting P, Beggs L, Sadek A, Lokuge K, Tomlinson E, Cooper C, James R, Zhang Y, Willans R, Webster L, Carroll J, Phillippo D, Wonderling D, Dangoor A, Chauhan D, O'Brien S, Welton NJ. PMID: 42246395 [PubMed - in process]
	Prognostic value of emotional distress in advanced non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Lin JJ, Zhou R, He ZY, Wang TL, Zhang ZX, Zhu YJ, He YH, Chang XS, Chen YD, Zhang HB. PMID: 42245743 [PubMed]
	Risk prediction models for venous thromboembolism in lung cancer patients after surgery: a systematic review and meta-analysis. Front Oncol Sun T, Chen Y, Shang X, Lin H, Wang Y, Wei H, Yang F. PMID: 42245741 [PubMed]
	Evolution and recent advances in antibody-drug conjugate therapy for lung cancer: a comprehensive systematic review based on the Trialtrove database (inception to July 1, 2025). Front Oncol Chen Y, Zhang Y, Tian C, Li Z, Guo G. PMID: 42245686 [PubMed]
	Gene amplification in the premalignant stages of non-small cell lung cancer development. Front Oncol Souza VGP, Bénard KH, Stewart GL, Enfield KSS, Lockwood WW, Lam WL. PMID: 42245683 [PubMed]
	Primary Pulmonary Mesenchymal Neoplasm With EWSR1::CREM Fusion: Cytologic Findings and Molecular Diagnosis. Diagn Cytopathol Upadhyay P, Mukhopadhyay S, Baskota SU. PMID: 42244043 [PubMed - as supplied by publisher]
	Radionuclideâ€‘drug conjugates in lung cancer: advances in precision therapy and clinical translation. Mol Cancer Liu J, Zuo X, Yang X, Wang X, Gan L, Xue J. PMID: 42243842 [PubMed - as supplied by publisher]
	Global, regional, and national trends in burden of lung cancer and chronic obstructive pulmonary disease and associated risk factors, 1990-2021: results from the global burden of disease study 2021. NPJ Prim Care Respir Med Qian J, Zhou S, Wang R, Wu Q, Meng J, Zhang J, Zhang Y. PMID: 42243105 [PubMed - as supplied by publisher]
	Chronic obstructive pulmonary disease as a systemic risk factor for cancer: a nationwide cohort study in Korea. BMJ Open Respir Res Kim JH, Kang HS, Yoo DM, Han KM, Kim NY, Choi HG, Kwon MJ. PMID: 42242829 [PubMed - in process]
	The diagnostic role of transbronchial lung cryobiopsy in inflammatory myeloid neoplasms. Respir Med Res Petrarulo S, Ravaglia C, Sultani F, Martinello S, Dubini A, Costantini M, Piciucchi S, Poletti V. PMID: 42241904 [PubMed - as supplied by publisher]
	Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective DiscoveryÂ andÂ Prospective Validation. Respirology Hirakawa T, Yamaguchi K, Takao S, Kanaji N, Matsumoto N, Miyazaki K, Okimoto T, Ando C, Higo H, Yanai M, Kurose K, Nagasaki Y, Watanabe M, Oyama K, Toyoda Y, Taguchi Y, Tada S, Shimoji K, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Iwamoto H, Hamada H, Hattori N. PMID: 42241716 [PubMed - as supplied by publisher]
	Erratum: Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers. J Cancer Res Ther PMID: 42241178 [PubMed - in process]
	Efficacy and safety of Xihuang pill/capsule as adjuvant therapy for lung cancer: A systematic review and meta-analysis. J Cancer Res Ther Guan Y, Xiao J, Wang J, Liang J, Xie Q, Ye X. PMID: 42241176 [PubMed - in process]
	Association between lipid metabolism and lung adenocarcinoma: Evidence from Mendelian randomization and tissue microbiome analysis. J Cancer Res Ther Chen Q, Xu Z, Zheng T, Pang H, He Z. PMID: 42241172 [PubMed - in process]
	A study on the antitumor effect and mechanism of arsenic trioxide on lung adenocarcinoma. J Cancer Res Ther Zheng Q, Liu H, Zhang Q, Guo N, Luo Q, Yang S, Zhang S, Chen X, Li N. PMID: 42241169 [PubMed - in process]
	Association between tissue origin classification and the clinical features and molecular phenotypes of nonsmall cell lung cancer. J Cancer Res Ther Zhou P, Tang R, Liu H, Wang N, Guo X, Qi H, Cheng Y, Jiang N, Qiu L, Sun Q. PMID: 42241162 [PubMed - in process]
	First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial. JAMA Oncol Liu J, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Shi J, Pan Z, Shi J, Wang X, Bai Y, Pan Y, Min X, Viguro M, Li X, Zhao Y, Yang J, Makharadze T, Arkania E, Yu H, Li J, Yang X, Wang Q, Zhu J, ASTRUM-005 Study Group. PMID: 42240984 [PubMed - as supplied by publisher]
	Pre-treatment quality of life and survival outcomes in lung cancer patients: a systematic review and meta-analysis. Support Care Cancer Avizova Z, Myssayev AO, Iztleuov YM, Mussin NM, Tamadon A. PMID: 42240738 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 160197

Page 1 of 8010



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy